Volume Disorders as a Mechanism of Multiple Organ Dysfunction Syndrome and Associated Lethality
DOI:
https://doi.org/10.61841/hkxq8s56Keywords:
Volume Status, Fluid-Related Sectoral Disorders,, Hypervolemia, Hypovolemia, MODS, SIRS, LethalityAbstract
The aim of the present study was to evaluate the significance of volume status in critically ill patients for assessment of volume status influence of fluid-related sectoral disorders on the associated lethality.
Methods. The authors studied 256 clinical cases of patients with multiple organ dysfunction syndrome aged from 18 to 78 (average age 62.4 ± 8.8) regardless of sex, hospitalized to units of resuscitation and intensive care.
The dynamics of general clinical parameters (central hemodynamics, respiratory status, pulseoxymetry parameters, hemoconcentration parameters, plasma albumins) was studied. The severity of patients conditions was assessed by three-level scale of intensive care patients condition severity, consciousness impairment – by Glasgow scale, volume status – by the severity and localization of edemas, presence of free fluid in organism cavities and central venous pressure. Body fluids and volume of circulating blood were measured by bioimpedance method. Infusion plan (volume, quality and ratio of media, fluid balance) was assessed. Multiple Organ Failure Scale along with the developed Scale of Fluid-Related Sectoral Disorders Evaluation was used for assessment of patients status in critical conditions and organ failure associated lethality.
Results. The authors identified 4 groups of patients by the severity of volume disorders: 49.6% of patients were in Group 2 (lethality in 20.8%); 27.4% were in Group 3 (lethality in 37.6%); 9.7% were in Group 4 (lethality in 72.5%); the rest patients were included into Group 1 (lethality in up to 10%). Direct correlation was identified between the severity of volume disorders and lethality. It was proved that volume disorders were one of the main consecutively determined mechanisms of multiple organ dysfunction syndrome development.
Conclusion. The infusion therapy for multiple organ dysfunction syndrome was primarily aimed at normalization of fluid-related sectoral homeostasis (normovolemia). For systematization of the parameters of fluid-related sectoral disorders, further distribution of the patients by the influence of the mentioned disorders on the disease outcome and dynamic control of volume status, the authors developed formalized scale for evaluation of volume disorders and prognosis of lethality risk in patients with multiple organ dysfunction syndrome.
Downloads
References
[1] Dats A.V., Gorbachev V.I., Gaskin I.Y., Popova M.A. Influence of hypervolemia on the severity of condition, organ damage and survival rate in patients in the intensive care unit [Vliyanie gipervoliemii na tyazhest sostoyaniya, organnye povrezhdeniya i vyzhivaemost patsientov otdeleniy intensivnoy terapii]. Polytravma. 2012. № 2. p. 31-34.
[2] Dats A.V., Gorbacheva S.M., Dats L.S. Evaluation and monitoring of the volume status and tissue perfusion in patients in critical condition [Otsenka i monitoring sostoyaniya volemii i tkanevoy perfuzii u patsientov v kriticheskom sostoyanii]. Methodical recommendations. Irkutsk State Medical Academy, Ministry of Healthcare of the RF, Irkutsk, 2014.
[3] Dats A.V., Gorbachov V.I. Etiology, clinical picture and intensive therapy for fluid balance disturbances at multiple organ dysfunction syndrome : monography [Etiologiya, klinicheskoe techenie i intensivnaya terapiya narusheniy vodnogo obmena pri syndrome poliorgannoy nedostatochnosti: monografiya]. Irkutsk, 2011. - 212 p.
[4] Dats A.V. Diagnostics and intensive therapy for early volume disorders at multiple organ failure: dissertation [Vyavlinie i intensivnaya terapiya rannikh volumeheskikh narusheniy pri poliorgannoy nedostatochnosty: dissertation] 14.01.20. Saint Petersburg, 2013. –245 p.
[5] Zhurova А.А., Ekstrem A.V., Popov A.S. Continuous low-volume infusion of hydroxyethylated starch as an option of fluid balance correction in patients with gestosis [Nepreryvnaya nizkoobiemnaya infusiya gydroksilirovannogo krakhmala kak variant korrektsii vodnogo obmena u bolnykh s gestozom]. Anesthesiology and Intensive Care. 2010. № 6. p. 68–71.
[6] Kuzkov V.V., Fot E.V., Smetkin A.A., Lebedinskiy K.M., Kirov M.Y. Volemic status and phase-based approach to the therapy for critical conditions – new possibilities and prospects [Volemicheskiy status i fazovy podkhod k terapii kriticheskikh sostoyaniy – novye vozmozhnosti i perspectivy]. Anesthesiology and Intensive Care. 2015. Т. 60. № 6. p. 65-70.
[7] Lukomskiy G.I., Alekseeva M.E. Volemic disorders in patients with surgical pathologies [Volemicheskie narusheniya pri khirurgicheskoy patologii]. М.: Medicine, 1988. 207 p.
[8] Pasechnik I.N., Skobelev E.I. Prospects of metabolic therapy for critical conditions [Perspektivy metabolicheskoy terapii kriticheskikh sostoyaniy]. Doctor.Ru. Therapy. Cardiology. Rheumatology.
№8(109) - 9(110), - 2015, p. 22-27.
[9] Uliyanov V.Y., Nikolenko V.N., Drozdova G.A., Norkin I.A. Traumatic disease of spinal cord: pathogenetic and sanogenetic elements of homeostasis [Travmaticheskaya bolezn spinnogo mozhga: patogeneticheskie i sanogeneticheskie zveniya gomeostaga]. Monography. 2016.
[10] Fastova I.A. Factors that influence on the development of multiple organ insufficiency and lethality risk increase at peritonitis [Faktory, vliyayuschie na razvitie poliorgannoy nedostatochnosti i uvelichenie riska letalnykh iskhodov pri peritonite]. Journal of New Medical Technologies. 2011. Т. 18. № 2. p. 80-83.
[11] Shlakhter S.M., Kazantseva O.N. Mechanisms of multiple organ failure development [Mekhanizmy razvitiya poliorgannoy nedostatochnosti]. Modern issues of fundamental and applied science. 2016. p. 101- 103
[12] Shlakhter S.M., Kazantseva O.N., Zhurova А.А. Correction of organism fluid sectors pathology at multiple organ dysfunction syndrome [Korrektsiya patologii vodnykh sektorov organizma pri syndrome poliorgannoy nedostatochnosti]. Modern issues of fundamental and applied science. 2016. p. 76-79.
[13] Ekstrem A.V., Popov A.S., Kazantsev D.A. Fluid sectors management at multiple organ dysfunction syndrome [Upravlenie vodnymi serktorami organizma pri syndrome poliorhannoy nedostatochnosti]. Fundamental Research. 2015. № 1-10. p. 2108-2112.
[14] Bouchard J. et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury // Kidney Int. 2009 Aug; 76(4):422-7
[15] Chong JU et al. Exploration of Fluid Dynamics in Perioperative Patients Using Bioimpedance Analysis // J Gastrointest Surg. 2016 May; 20(5):1020-7.
[16] Almeida JP, Palomba H, Galas FR, Fukushima JT, Duarte FA, Nagaoka D, Torres V, Yu L, Vincent JL, Auler JO Jr, Hajjar LA. Positive fluid balance is associated with reduced survival in critically ill patients with cancer. Acta Anaesthesiol Scand. 2012 Jul; 56(6): 712-7. Epub 2012 May 23.
[17] Johnson P. Practical Assessment of Volume Status in Daily Practice. Top Companion Anim Med. 2016 Sep; 31(3):86-93.
[18] Kreimeier U. Pathophysiology of fluid imbalance. Crit Care. 2000; 4 Suppl 2:S3-7.
[19] Silva PL, Cruz FF, Fujisaki LC et al. Hypervolemia induces and potentiates lung damage after recruitment maneuver in a model of sepsis-induced acute lung injury. Crit Care. 2010; 14(3):R114.
[20] Vallet M, Jaafar A, Charles PY, Tack I. Which biological parameters for volemic status estimation?
Nephrol Ther. 2018 Apr; 14 Suppl 1:S83-S88.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
